278 related articles for article (PubMed ID: 18559516)
1. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
[TBL] [Abstract][Full Text] [Related]
3. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
4. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo.
Postea O; Koenen RR; Hristov M; Weber C; Ludwig A
J Cell Mol Med; 2008; 12(5A):1700-9. PubMed ID: 18194461
[TBL] [Abstract][Full Text] [Related]
6. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
[TBL] [Abstract][Full Text] [Related]
8. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
Hu W; Liu Y; Zhou W; Si L; Ren L
PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
[TBL] [Abstract][Full Text] [Related]
9. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
[TBL] [Abstract][Full Text] [Related]
10. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
Lv Y; Hou X; Ti Y; Bu P
Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
[TBL] [Abstract][Full Text] [Related]
11. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
[No Abstract] [Full Text] [Related]
12. The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro.
Gruber HE; Marrero E; Ingram JA; Hoelscher GL; Hanley EN
Biotech Histochem; 2017; 92(1):7-14. PubMed ID: 27869573
[TBL] [Abstract][Full Text] [Related]
13. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
14. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.
Nanki T; Shimaoka T; Hayashida K; Taniguchi K; Yonehara S; Miyasaka N
Arthritis Rheum; 2005 Oct; 52(10):3004-14. PubMed ID: 16200580
[TBL] [Abstract][Full Text] [Related]
17. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
18. Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.
Tabata S; Kadowaki N; Kitawaki T; Shimaoka T; Yonehara S; Yoshie O; Uchiyama T
J Leukoc Biol; 2005 May; 77(5):777-86. PubMed ID: 15703197
[TBL] [Abstract][Full Text] [Related]
19. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641
[TBL] [Abstract][Full Text] [Related]
20. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]